Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?

OBJECTIVES:. To examine whether interleukin-6 in critical coronavirus disease 2019 is higher in arterial than in central venous blood, as a sign of predominantly local pulmonal rather than systemic interleukin-6 production. DESIGN:. Prospective cohort pilot study with repeated weekly measurements of...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikolai Ravn Aarskog, MD, Hans Christian Aass, PhD, Jan Cato Holter, MD, PhD, Morten Rostrup, MD, PhD, Aleksander Rygh Holten, MD, PhD
Format: article
Language:EN
Published: Wolters Kluwer 2021
Subjects:
Online Access:https://doaj.org/article/77ff7ef076ce42c0bd7b814e4a482e9c
Tags: Add Tag
No Tags, Be the first to tag this record!